Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Yunfeng Financial Group Limited (0376.HK)
Wan Chai, HK
Yunfeng Financial Group Limited operates as an investment holding company, primarily engaging in the provision of diverse insurance products across Hong Kong and Macau. Its operations are structured into two principal segments: Insurance Products, and Other Financial Services and Corporate. Within its insurance arm, the company delivers a comprehensive suite of offerings, including life and medical coverage, annuities, pension plans, and mandatory provident fund (MPF) schemes. Beyond insurance, Yunfeng Financial extends its expertise to diverse financial services. These encompass fund and asset management, along with tailored financing and investment solutions. It also offers corporate advisory services and plays a role in securities placement and underwriting. Its broader financial offerings include the administration of employee stock ownership plans (ESOPs) and principal investment activities. Furthermore, the Group provides a range of supporting services, such as administrative, trustee, and general support, alongside acting as an agency for non-life insurers, and offering marketing, promotion, and public relations expertise. The company also has a significant presence in technology, developing internet and multimedia systems, applications, and offering comprehensive technological development for software and hardware, technical consulting, and specialized services related to databases and computer networks. Established in 1982 and headquartered in Wanchai, Hong Kong, the company previously operated under the name REORIENT GROUP LIMITED before adopting its current moniker, Yunfeng Financial Group Limited, in October 2016. It functions as a subsidiary of Yunfeng Financial Holdings Limited.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -3.27% | -4.17% | -22.47% | -32.79% | -45.53% | -34.49% | +18.29% | +83.19% | -26.33% | -68.25% | -92.04% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2024-11 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 0 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Insurance - Life: +10.6%+56.2% ★ Q4'25: +59.8% (vs Q4'23)
-
EPS growth Insurance - Life: +13.4%+41.7% ★ Q4'25: -39.0% (vs Q4'23)
-
FCF margin FCF growth · Insurance - Life: +31.7%+5.5% ★ Q4'25: -9.8% (vs Q4'23)
-
EBIT margin Insurance - Life: +12.4%+18.6% ★ Q4'25: +9.7% (vs Q4'23)
-
ROIC Insurance - Life: +1.0%+8.0% ★ Q4'25: +9.7% (vs Q4'23)
-
Share dilution Insurance - Life: +0.4%+1.4% Q4'25: +5.0% (vs Q4'23)
-
Debt / EBITDA Net debt/EBITDA · Insurance - Life: -1.05×1.62× ★ Q4'25: 1.31× (vs Q4'23)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 1 Rev. Ana. 1 EPS Ana. |
Dec 2027 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|
| Revenue |
4.87B
est: 4.87B (+0.0%)
|
7.61B
est: 7.61B (+0.0%)
|
8.89B
8.89B – 8.89B
+16.9% YoY
|
10.39B
10.39B – 10.39B
+16.9% YoY
|
| EBITDA |
1.13B
est: 611.28M (+85.6%)
|
1.60B
est: 1.04B (+53.8%)
|
1.22B
1.22B – 1.22B
+16.9% YoY
|
1.42B
1.42B – 1.42B
+16.9% YoY
|
| EBIT |
1.13B
est: 479.87M (+136.0%)
|
1.41B
est: 798.41M (+77.2%)
|
933.00M
933.00M – 933.00M
+16.9% YoY
|
1.09B
1.09B – 1.09B
+16.9% YoY
|
| Net Income |
470.79M
est: 256.66M (+83.4%)
|
652.55M
est: 260.15M (+150.8%)
|
340.10M
340.10M – 340.10M
+30.7% YoY
|
445.40M
445.40M – 445.40M
+31.0% YoY
|
| SGA |
869.93M
est: 873.47M (-0.4%)
|
—
est: 1.17B (-100.0%)
|
1.37B
1.37B – 1.37B
+16.9% YoY
|
1.60B
1.60B – 1.60B
+16.9% YoY
|
| EPS |
0.12
est: 0.07 (+80.1%)
|
0.17
est: 0.07 (+155.2%)
|
0.09
0.09 – 0.09
+30.7% YoY
|
0.11
0.11 – 0.11
+31.0% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-29 | B+ | 3/5 | 5/5 | 2/5 | 3/5 | 3/5 | 2/5 | 3/5 |
| 2026-05-28 | B+ | 3/5 | 5/5 | 2/5 | 3/5 | 3/5 | 2/5 | 3/5 |
| 2026-05-27 | B+ | 3/5 | 5/5 | 2/5 | 3/5 | 3/5 | 2/5 | 3/5 |
| 2026-05-26 | B+ | 3/5 | 5/5 | 2/5 | 3/5 | 3/5 | 2/5 | 3/5 |
| 2026-05-22 | B+ | 3/5 | 5/5 | 2/5 | 3/5 | 3/5 | 2/5 | 3/5 |
| 2026-05-21 | B+ | 3/5 | 5/5 | 2/5 | 3/5 | 3/5 | 2/5 | 3/5 |
| 2026-05-20 | B+ | 3/5 | 5/5 | 2/5 | 3/5 | 3/5 | 2/5 | 3/5 |
| 2026-05-19 | B+ | 3/5 | 5/5 | 2/5 | 3/5 | 3/5 | 2/5 | 3/5 |
| 2026-05-18 | B+ | 3/5 | 5/5 | 2/5 | 3/5 | 3/5 | 2/5 | 3/5 |
| 2026-05-15 | B+ | 3/5 | 5/5 | 2/5 | 3/5 | 3/5 | 2/5 | 3/5 |
| 2026-05-14 | B+ | 3/5 | 5/5 | 2/5 | 3/5 | 3/5 | 2/5 | 3/5 |
| 2026-05-13 | B | 3/5 | 5/5 | 2/5 | 3/5 | 3/5 | 1/5 | 3/5 |
| 2026-05-12 | B | 3/5 | 5/5 | 2/5 | 3/5 | 3/5 | 1/5 | 3/5 |
| 2026-05-11 | B | 3/5 | 5/5 | 2/5 | 3/5 | 3/5 | 1/5 | 3/5 |
| 2026-05-08 | B+ | 3/5 | 5/5 | 2/5 | 3/5 | 3/5 | 2/5 | 3/5 |
| 2026-05-07 | B+ | 3/5 | 5/5 | 2/5 | 3/5 | 3/5 | 2/5 | 3/5 |
| 2026-05-06 | B+ | 3/5 | 5/5 | 2/5 | 3/5 | 3/5 | 2/5 | 3/5 |
| 2026-05-05 | B+ | 3/5 | 5/5 | 2/5 | 3/5 | 3/5 | 2/5 | 3/5 |
| 2026-05-04 | B+ | 3/5 | 5/5 | 2/5 | 3/5 | 3/5 | 2/5 | 3/5 |
| 2026-04-30 | B | 3/5 | 5/5 | 2/5 | 3/5 | 2/5 | 2/5 | 3/5 |
| 2026-04-29 | B | 3/5 | 5/5 | 2/5 | 3/5 | 2/5 | 2/5 | 3/5 |
| 2026-04-28 | B | 3/5 | 5/5 | 2/5 | 3/5 | 2/5 | 2/5 | 3/5 |
| 2026-04-27 | B | 3/5 | 5/5 | 2/5 | 3/5 | 2/5 | 2/5 | 3/5 |
| 2026-04-24 | B | 3/5 | 5/5 | 2/5 | 3/5 | 2/5 | 2/5 | 3/5 |
| 2026-04-23 | B+ | 3/5 | 5/5 | 2/5 | 4/5 | 2/5 | 2/5 | 3/5 |
| 2026-04-22 | B+ | 3/5 | 5/5 | 2/5 | 4/5 | 2/5 | 2/5 | 3/5 |
| 2026-04-21 | B+ | 3/5 | 5/5 | 3/5 | 4/5 | 2/5 | 2/5 | 3/5 |
| 2026-04-20 | B+ | 3/5 | 5/5 | 3/5 | 4/5 | 2/5 | 2/5 | 3/5 |
| 2026-04-17 | B+ | 3/5 | 5/5 | 3/5 | 4/5 | 2/5 | 2/5 | 3/5 |
| 2026-04-16 | B+ | 3/5 | 5/5 | 3/5 | 4/5 | 2/5 | 2/5 | 3/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | State Street SPDR S&P International Small Cap ETF GWX | 0.02% | 214.8K | 0.40% |
| 2 | FlexShares Morningstar Developed Markets ex-US Factor Tilt Index Fund TLTD | 0.02% | 134.1K | 0.41% |
| 3 | Dimensional - International Vector Equity ETF DXIV | 0.01% | 12.1K | 0.53% |
| 4 | Dimensional - International Small Cap Value ETF DISV | 0.00% | 160.7K | 0.42% |
| 5 | Dimensional - International Small Cap ETF DFIS | 0.00% | 123.3K | 0.39% |
| 6 | Dimensional - International Core Equity 2 ETF DFIC | 0.00% | 78.2K | 0.22% |
| 7 | Dimensional - International Core Equity Market ETF DFAI | 0.00% | — | 0.18% |
| 8 | Dimensional International Sustainability Core 1 ETF DFSI | 0.00% | — | 0.24% |
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Guofei Jiang | President | — | male |
| Liu Zhiguang | Chief Operating Officer | — | male |
| Man Ko Chan | Chief Financial Officer, Senior MD & Company Secretary | — | male |
| Xin Huang | Interim Chief Executive Officer & Executive Director | — | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for 0376.HK
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
